Afuco™ Anti-Human CTLA4 ADCC Therapeutic Antibody (JMW-3B3), ADCC Enhanced
Anti-CTLA4 ADCC Enhanced Antibody (JMW-3B3) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a monoclonal antibody to investigate whether sCTLA-4 is important in controlling immune responses particularly in SLE patients. The anti-sCTLA-4 antibody is currently being humanised as a potential therapy for the treatment of some cancers.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-185CL |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CTLA4 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles. |